schaftoside has been researched along with acetaminophen in 1 studies
| Studies (schaftoside) | Trials (schaftoside) | Recent Studies (post-2010) (schaftoside) | Studies (acetaminophen) | Trials (acetaminophen) | Recent Studies (post-2010) (acetaminophen) |
|---|---|---|---|---|---|
| 18 | 0 | 15 | 20,696 | 2,848 | 8,242 |
| Protein | Taxonomy | schaftoside (IC50) | acetaminophen (IC50) |
|---|---|---|---|
| Myoglobin | Homo sapiens (human) | 2.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Gao, Y; Huang, X; Lin, C; Liu, C; Liu, M; Mi, S; Shen, C; Song, M; Wang, J; Zhang, G; Zhu, C | 1 |
1 other study(ies) available for schaftoside and acetaminophen
| Article | Year |
|---|---|
Activation of Farnesoid X Receptor by Schaftoside Ameliorates Acetaminophen-Induced Hepatotoxicity by Modulating Oxidative Stress and Inflammation.
Topics: Acetaminophen; Animals; Antioxidants; Chemical and Drug Induced Liver Injury; Glycosides; Inflammation; Metabolic Networks and Pathways; Mice; Oxidative Stress; Protective Agents; Receptors, Cytoplasmic and Nuclear; Secondary Metabolism; Signal Transduction | 2020 |